Skip to content

Evaluate the Effect of Fluoride-Releasing Composite Resin on Prevention of White Spot Lesions During Clear Aligner Therapy

Evaluate the Effect of Fluoride-Releasing Composite Resin on Prevention of White Spot Lesions During Clear Aligner Therapy: A Controlled Split-Mouth Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07426432
Enrollment
24
Registered
2026-02-23
Start date
2025-08-01
Completion date
2026-09-01
Last updated
2026-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clear Aligner Appliance, White Spot Lesions

Brief summary

Aim of this study: evaluate the effect of fluoride-releasing composite resin as attachments on prevention of white spot lesions. Material and methods: Type: Prospective, randomized split mouth controlled study. Interventions: Intervention Group (Experimental Side): •Application of fluoride-releasing composite Control Group (Control Side): •Application of conventional composite Outcome Measures: Primary Outcome: Incidence and Severity of White Spot Lesions Secondary Outcomes: 1. Periodontal Ligament (PDL) Health 2. Gingival Bleeding and Inflammation

Detailed description

Aim of the Study: The aim of this study is to evaluate the effect of fluoride-releasing composite resin as attachments on prevention of white spot lesions (WSLs) development during clear aligner therapy in comparison to a split-mouth controlled group. Material and methods: Study Design: Each participant will have one side of the mouth assigned to fluoride-releasing composite intervention as attachments, while the contralateral side will be assigned to conventional composite as attachments. Sample size calculation: Sample size calculation was based on effect of fluoride-releasing composite resin on prevention of White Spot Lesions during Clear Aligner Therapy: that was retrieved from most similar research Abdullah et al. Using G power program version 3.1.9.7 to calculate sample size based on effect size of 1.08 that is based on mean area of white spots, using 2-tailed test, α error = 0.05 and power = 95% , the total calculated sample size will be 24 in each group. To mitigate the potential impact of an anticipated 20% dropout rate, the recruitment target was increased to 30 patients per treatment group, aiming to ensure adequate statistical power in the final analyzed sample. Inclusion Criteria: * Patients aged 16-24 years. * Good general and oral health. * Mild dental crowding per arch (≤ 4 mm). Exclusion Criteria: * Systemic conditions affecting tooth movement (e.g., diabetes, bone disorders). * Patients with Cleft lip and palate. * Previous orthodontic treatment. * Dental fluorosis. * Hypocalcified teeth or visible demineralization. Interventions: 1. Initial Oral Scan: A 3D oral scan of the arch to be treated will be performed using a digital intraoral scanner 2. Aligner Fabrication: Aligners will be fabricated using thermoforming techniques. Intervention Group (Experimental Side): application of a fluoride-releasing composite on the indicated side of the mouth as attachments. Control Group (Control Side): application of conventional composite as attachments. 3. Aligner Placement: the aligners will be fitted, and patients will wear them continuously, except during eating and brushing. Outcome Measures: Primary Outcome: Incidence and Severity of White Spot Lesions Measured at base line, third (T1) and sixth (T2) months. 1.Laser fluorescence (DIAGNOdent), lesion defined as having a numerical score equal to or higher than (14). Secondary Outcome: 1. Periodontal Ligament (PDL) Health using: Pocket Depth Index (PDI) 2. Gingival Bleeding and Inflammation Duration of the study: •This study is suggested to be finished in 12 months.

Interventions

OTHERApplication of fluoride-releasing composite

using fluoride releasing composite for attachment construction

OTHERApplication of conventional composite

using non fluoridated composite for attachment construction

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients aged 16-24 years. * Good general and oral health. * Mild dental crowding per arch (≤ 4 mm).

Exclusion criteria

* Systemic conditions affecting tooth movement (e.g., diabetes, bone disorders). * Patients with Cleft lip and palate. * Previous orthodontic treatment. * Dental fluorosis. * Hypocalcified teeth or visible demineralization.

Design outcomes

Primary

MeasureTime frameDescription
White Spot Lesionssix monthsIncidence and Severity of White Spot Lesions Measured at baseline, third (T1) and sixth (T2) months, by Laser fluorescence (DIAGNOdent), lesion defined as having a numerical score equal to or higher than (14).

Secondary

MeasureTime frameDescription
Periodontal Ligament (PDL) Healthsix monthsPeriodontal Ligament (PDL) Health using: * Pocket Depth Index (PDI), by periodontal probe 1. 1-3 mm: Healthy or mild inflammation. 2. 4-5 mm: Moderate periodontal disease. 3. ≥6 mm: Severe periodontal disease with potential bone loss.
Gingival Bleeding and Inflammationsix monthsGingival Bleeding Index (GBI) Dichotomous (yes/no bleeding) no=0 yes=1

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026